Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Therapeutic Effects of Mesenchymal Stem Cell (Mscs) Exosomes in Covid-19 Disease; Focusing on Dexamethasone Therapy Publisher Pubmed



Derafsh E1 ; Ebrahimzadeh F2 ; Kahrizi MS3 ; Kayedi M4 ; Shojaei N5 ; Rahimi S6 ; Alesaeidi S7 ; Ghafouri K8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Basic Medical Science, Windsor University School of Medicine, Brighton's Estate, Cayton, Saint Kitts and Nevis
  2. 2. Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  3. 3. Alborz University of Medical Sciences, Alborz, Karaj, Iran
  4. 4. Department of radiology. Shiraz university of medical sciences, Shiraz, Iran
  5. 5. School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  6. 6. School of medicine, fasa university of medical sciences, Fasa, Iran
  7. 7. Department of Internal medicine and rheumatology, �Rheumatology Research Center�, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Pathology Research and Practice Published:2023


Abstract

The study of diseases, specifically their aetiologies, their step-by-step progressions (pathogenesis), and their impact on normal structure and function, is the focus of pathology, a branch of science and medicine. In therapeutic fields, it is critical to decrease significantly elevated levels of proinflammatory cytokines. The immunomodulatory drugs such as dexamethasone have been used in several of inflammatory diseases such as Covid-19. The use of dexamethasone alone or in combination with other drugs or method such as mesenchymal stem cell (MSC) is one of the most up-to-date discussions about Covid-19. In this review, we first examined the effects of dexamethasone as monotherapy on inflammatory cytokines and then examined studies that used combination therapy of dexamethasone and other drugs such as Baricitinib, Tofacitinib and tocilizumab. Also, therapeutic aspects of MSCs are examined in this review. © 2023 Elsevier GmbH
Related Docs
View other Related Docs
1. Mesenchymal Stem/Stromal Cells As a Valuable Source for the Treatment of Immune-Mediated Disorders, Stem Cell Research and Therapy (2021)
2. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
3. Conquering the Cytokine Storm in Covid-19-Induced Ards Using Placenta-Derived Decidua Stromal Cells, Journal of Cellular and Molecular Medicine (2021)
4. An Overview of the Recent Findings of Cell-Based Therapies for the Treatment and Management of Covid-19, International Immunopharmacology (2021)
5. Covid-19 Associated Thrombotic Thrombocytopenic Purpura (Ttp); a Case Series and Mini-Review, International Immunopharmacology (2021)
6. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
7. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
8. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (5)
Abdolrahman Rostamian (1)
Other Related Docs
9. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)
10. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
11. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe Covid-19 Patients, Current Stem Cell Research and Therapy (2024)
12. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
13. Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action, Life Sciences (2020)
14. Jak Inhibitors in Solid Organ Transplantation, Journal of Clinical Pharmacology (2023)
15. Oral Nano-Curcumin Formulation Efficacy in the Management of Mild to Moderate Outpatient Covid-19: A Randomized Triple-Blind Placebo-Controlled Clinical Trial, Food Science and Nutrition (2021)
16. Sars-Cov-2 and Covid-19, Evidence From a Literature Review: Review Article, Tehran University Medical Journal (2021)
17. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
18. Intravenous Methylprednisolone Pulse As a Treatment for Hospitalised Severe Covid-19 Patients: Results From a Randomised Controlled Clinical Trial, European Respiratory Journal (2020)
19. The Critical Role of Mesenchymal Stromal/Stem Cell Therapy in Covid-19 Patients: An Updated Review, Cell Biochemistry and Function (2021)
20. Tocilizumab in Icu-Admitted Covid-19 Patients: A Retrospective Study, Medical Journal of the Islamic Republic of Iran (2023)
21. Mesenchymal Stromal/Stem Cells (Mscs) and Msc-Derived Extracellular Vesicles in Covid-19-Induced Ards: Mechanisms of Action, Research Progress, Challenges, and Opportunities, International Immunopharmacology (2021)
22. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
23. Molecular Aspects of Co-Morbidities in Covid-19 Infection, Archives of Bone and Joint Surgery (2020)
24. Oral Antiviral Treatments for Covid-19: Opportunities and Challenges, Pharmacological Reports (2022)
25. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
26. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
27. The Potential Use of Mesenchymal Stem Cells-Derived Exosomes As Micrornas Delivery Systems in Different Diseases, Cell Communication and Signaling (2023)
28. A Year of Experience With Covid-19 in Patients With Cancer: A Nationwide Study, Cancer Reports (2023)
29. Strongyloides Coinfection in Covid-19 Patients Treated With Corticosteroids: A Systematic Review, Reviews in Medical Virology (2023)
30. Predictors of the Prolonged Recovery Period in Covid-19 Patients: A Cross-Sectional Study, European Journal of Medical Research (2021)
31. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
32. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
33. Cardiovascular Manifestations in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Cardiovascular and Thoracic Research (2021)
34. Stem Cell Therapy Potency in Personalizing Severe Covid-19 Treatment, Stem Cell Reviews and Reports (2021)
35. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)
36. The Role of Mesenchymal Stromal Cells in Immune Modulation of Covid-19: Focus on Cytokine Storm, Stem Cell Research and Therapy (2020)
37. Human Placenta-Derived Mesenchymal Stem Cells Transplantation in Patients With Acute Respiratory Distress Syndrome (Ards) Caused by Covid-19 (Phase I Clinical Trial): Safety Profile Assessment, Stem Cell Research and Therapy (2022)
38. Efficacy and Safety of Tocilizumab, Plasmapheresis and Their Combination in Severe Covid-19: A Randomized Clinical Trial, International Immunopharmacology (2023)
39. Jak Inhibition As a New Treatment Strategy for Patients With Covid-19, International Archives of Allergy and Immunology (2020)